Phase 1 Fibromyalgia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 65 years old
- You are either a healthy volunteer, have been diagnosed with Multiple Sclerosis (MS), meet the criteria for fibromyalgia, or meet the criteria for Chronic Fatigue Syndrome
Who may not be able to join:
- You cannot have an MRI scan for any reason (for example, if you have certain metal implants or a pacemaker)
- You are currently pregnant
- You are currently breastfeeding
- Your medical condition is too severe to allow you to take part in the imaging (scanning) part of the study
- You have a long-term infectious disease such as HIV or hepatitis C
- You have had a viral or bacterial illness that needed medical treatment or antibiotics in the past month
- You have been diagnosed with any type of cancer, including leukemia
- You have a blood disorder or a problem with blood clotting
- You have been diagnosed with an autoimmune disease (unless your autoimmune condition is MS)
- A pregnancy test taken on the day of the procedure, or within 48 hours before a specific imaging drug is given, comes back positive
- You are currently taking part in another clinical trial that involves experimental treatments
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 205-975-5907
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Neuroinflammation will be measured in healthy volunteers and compared to neuroinflammation in individuals with pain and fatigue, as measured with [F-18]DPA-714-PET/MRI.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.